Product NDC: | 0023-8694 |
Proprietary Name: | AZELEX |
Non Proprietary Name: | azelaic acid |
Active Ingredient(s): | .2 g/g & nbsp; azelaic acid |
Administration Route(s): | CUTANEOUS |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-8694 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020428 |
Marketing Category: | NDA |
Start Marketing Date: | 19960321 |
Package NDC: | 0023-8694-30 |
Package Description: | 1 TUBE in 1 CARTON (0023-8694-30) > 30 g in 1 TUBE |
NDC Code | 0023-8694-30 |
Proprietary Name | AZELEX |
Package Description | 1 TUBE in 1 CARTON (0023-8694-30) > 30 g in 1 TUBE |
Product NDC | 0023-8694 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | azelaic acid |
Dosage Form Name | CREAM |
Route Name | CUTANEOUS |
Start Marketing Date | 19960321 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | AZELAIC ACID |
Strength Number | .2 |
Strength Unit | g/g |
Pharmaceutical Classes | Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] |